Wishpond est l'un des meilleurs choix pour 2023.

de lecture

Article

Disponible en anglais seulement.

The stock ended 2022 in the red, but investors can expect better results this year from Wishpond Technologies (Wishpond Technologies Stock Quote, Charts, News, Analysts, Financials TSXV:WISH). That’s according to iA Capital Markets analyst Neehal Upadhyaya, who nominated WISH as one of his two Top Picks in Technology for the year ahead.

En savoir plus.

Source : Cantech Letter

Actualités connexes

Algonquin Power ne passe toujours pas, selon iA Capital Markets

de lecture

Disponible en anglais seulement. iA Capital Markets analyst Naji Baydoun is still skeptical about Algonquin Power & Utilities (Algonquin Power & Utilities Stock Quote, Charts, News, Analysts, Financials TSX:AQN), saying in a review of the company’s latest quarterly numbers that investors should wait to see how well the utility company fares on this year’s strategic priorities. En savoir plus. Source : Cantech Letter
Acheter Innergex dans le secteur de l'énergie renouvelable, affirme iA Marchés des capitaux.

de lecture

Disponible en anglais seulement. iA Capital Markets analyst Naji Baydoun delivered an update on Friday on Innergex Renewable Energy (Innergex Renewable Energy Stock Quote, Charts, News, Analysts, Financials TSE:INE) where he reviewed the company’s just-released fourth quarter results, saying the company has a strong growth outlook and declining payout ratio. En savoir plus. Source: Cantech Letter
Exchange Income Corp obtient une augmentation cible de iA Marchés des capitaux.

de lecture

Disponible en anglais seulement. Organic and inorganic growth as well as higher margins look to be in the cards for Exchange Income Corp (Exchange Income Stock Quote, Charts, News, Analysts, Financials TSX:EIF), according to iA Capital Markets analyst Matthew Weekes. En savoir plus. Source: Cantech Letter
Arch Biopartners se dirige vers un prix de 6 $, selon iA Marchés des capitaux.

de lecture

Disponible en anglais seulement. iA Capital Markets analyst Chelsea Stellick is staying bullish on Canadian biotech company Arch Biopartners (Arch Biopartners Stock Quote, Charts, News, Analysts, Financials TSXV:ARCH), saying in a Tuesday report that the company is ready to ramp up its clinical development programs. En savoir plus. Source: Cantech Letter
Les actions du secteur de la santé semblent attrayantes, selon iA Marchés des capitaux.

de lecture

Disponible en anglais seulement. Investors should be gearing up for some movement in the biotech space, says iA Capital Markets analyst Chelsea Stellick, who released a Healthcare sector report on Wednesday where she provided updates on 17 stocks under coverage. En savoir plus. Source: Cantech Letter